Can Aridol give Arna Pharma and Slate Run a sharper entry into U.S. respiratory diagnostics?
Specialty pharma needs sharper U.S. routes to market. Arna Pharma and Slate Run are testing that model with Aridol and 505(b)(2) products.
Why FDA’s clearance of ACON’s Flowflex Plus test marks a turning point in home diagnostics
FDA clears Flowflex Plus 4-in-1 test for RSV, flu, and COVID in infants and adults. Find out what this means for diagnostics, families, and industry players.